CVS HEALTH Corp
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
What Should CVS Stock Investors Be Watching Now?
If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?
CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth
CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom
CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of
CVS Health: Buy The Pullback Before Earnings Power Ramps Up
CVS Health looks undervalued at 12x forward P/E as revenue and operating income rebound; learn key catalysts, risks, and why a Buy may fitâread now.
CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
CVS Health Corporation (CVS) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 9:30 AM EDTCompany ParticipantsBrian Newman - Executive VP...
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.
CVS Health Marks 20 Years of Free Community Health Screening Program As New Survey Reveals Many U.S. Adults Still Face Barriers to Preventive Health Screenings
Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 9, 2026 / New survey findings commissioned by ® (NYSE:CVS) reveal that many Americans face persistent barriers accessing preventive health screenings. Nearly one in four adults have delayed speaking with a health professional about health concerns because of barriers related to access, cost or availability, and one-third were unaware that community screening programs exist.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Here's How CVS Is Focusing on Aetna's Profitability Turnaround
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
Congressional Trades in $CVS
Insider Trades (Form 4)
AGUIRRE FERNANDO
Key People
AGUIRRE FERNANDO
Director
Political Giving
$313,555 given to 57 candidates across 142 disclosed contributions (FEC Schedule A).
Katherine M. Clark
Bradley S. Schneider
John B. Larson
Guy Mr Reschenthaler
Kevin Hern
Blake Moore
Seth Magaziner
Terri A. Sewell
Gus M. Bilirakis
Darin McKay LaHood
Suzan K. DelBene
Adrian Smith
Linda T. Sanchez
Bill Hagerty
Ashley Moody
Ann Wagner
Kathy Castor
Jamie Raskin
Jennifer McClellan
James D Jordan
+ 37 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro